Results 171 to 180 of about 14,201,106 (332)

DeResA: a DEsign RESearch Approach [PDF]

, 2006
Slettenhaar, H.K., Vries, S.A. de
core   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

Adjustable prosthetic sockets: a systematic review of industrial and research design characteristics and their justifications. [PDF]

J Neuroeng Rehabil, 2023
Baldock M, Pickard N, Prince M, Kirkwood S, Chadwell A, Howard D, Dickinson A, Kenney L, Gill N, Curtin S, Curtin S.   +10 more
europepmc   +1 more source

Design and research of a new kind of minimally invasive fixation device in orthopaedics

, 2011
Xiangdang
openalex   +1 more source

Research on Optimized Design of In-Vessel Retention–External Reactor Vessel Cooling Strategy and Negative Effect Assessment

, 2022
Peng Chen, Wu Zhi, Dekui Zhan, Shaoxiong Xia, Xinhai Zhao   +4 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Editor’s Newsletter

Australasian Orthodontic Journal, 1987
doaj   +1 more source

A cost-effective mesocosm framework for reptile research: Design, validation, and practical insights. [PDF]

PLoS One
Simbula G, Barroso FM, Saçdanaku E, Ene G, Fănaru G, Sreelatha LB, Vizireanu MG, Roumelioti M, Boskovits NM, Vlad SE, Aguilar P, Carretero MA.   +11 more
europepmc   +1 more source

Redox Profile of Skeletal Muscles: Implications for Research Design and Interpretation. [PDF]

Antioxidants (Basel), 2023
Vasileiadou O, Nastos GG, Chatzinikolaou PN, Papoutsis D, Vrampa DI, Methenitis S, Margaritelis NV.   +6 more
europepmc   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source